Consensus Greenwich LifeSciences, Inc.

Equities

GLSI

US3968791083

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2024 am IST			5-day change	1st Jan Change
13.63 ^USD	-1.73%		+9.74%	+29.56%

15/04	Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/04	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ

Evolution of the average Target Price on Greenwich LifeSciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c439d706d33b99dbf95e.UxeA80NhfEmr4VvVrbzXRnabAWeZvHuf-nYJEmDxmQg.AEPZkTkXTS76hWOC8sq_LCLsdSHe5EOpiy5TRz-Q8kF-e7SdLyA5MN6Hbw~18356a9ad2eba8d8de767a44254e175c

Analyst Recommendations on Greenwich LifeSciences, Inc.

HC Wainwright Adjusts Greenwich LifeSciences Price Target to $36 From $38, Maintains Buy Rating	20/02	MT
HC Wainwright Cuts Greenwich LifeSciences' Price Target to $38 From $78, Keeps Buy Rating	10/23/10	MT
GREENWICH LIFESCIENCES : HC Wainwright Starts Greenwich LifeSciences at Buy with $78 Price Target	01/21/01	MT
GREENWICH LIFESCIENCES : Aegis Capital Initiates Coverage on Greenwich LifeSciences at Buy Rating, Sets Price Target at $75	26/21/26	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.87 USD

Average target price

36 USD

Spread / Average Target

+159.55%

High Price Target

36 USD

Spread / Highest target

+159.55%

Low Price Target

36 USD

Spread / Lowest Target

+159.55%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Greenwich LifeSciences, Inc.

HC Wainwright
Aegis Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar